|drug2583||Plasma exchange and convalescent plasma Wiki||1.00|
|D009102||Multiple Organ Failure NIH||0.45|
|D058186||Acute Kidney Injury NIH||0.21|
There is one clinical trial.
This study will monitor physical bio-markers such as heart rate, respiratory rate, and temperature to detect potential COVID-19 infections.
Description: Device data measuring cough count. Captured by analysis of peak acclerometer graphing and duration in meters per second squared (m/s2).Measure: 1.Efficacy of wearable device to detect respiratory infection parameters: cough count Time: 1 year
Description: WURSS-11 survey. https://www.fammed.wisc.edu/files/webfm-uploads/documents/research/wurss-11.pdf The WURSS-11 survey will be conducted on a weekly basis by study subjects for the duration of the study (up to 52 weeks).Measure: 2.Monitoring of respiratory infection symptoms, WURSS-11 Survey Time: Time Frame: 1 year
Data processed on January 01, 2021.
An HTML report was created for each of the unique drugs, MeSH, and HPO terms associated with COVID-19 clinical trials. Each report contains a list of either the drug, the MeSH terms, or the HPO terms. All of the terms in a category are displayed on the left-hand side of the report to enable easy navigation, and the reports contain a list of correlated drugs, MeSH, and HPO terms. Further, all reports contain the details of the clinical trials in which the term is referenced. Every clinical trial report shows the mapped HPO and MeSH terms, which are also hyperlinked. Related HPO terms, with their associated genes, protein mutations, and SNPs are also referenced in the report.Drug Reports MeSH Reports HPO Reports